Trademark: NOVARTIS
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for NOVARTIS
We do not have any records of a proof of use for NOVARTIS at this moment.
Possible trademark infringements of NOVARTIS
Basic Information about NOVARTIS
- Serial Number
- 79209927
- Filing Date
- 29 Nov 2016
- Registration Number
- 5420583
- Registration Date
- 13 Mar 2018
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of NOVARTIS on the blockchain with WikiTrademarks.io.
- First use of NOVARTIS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- G
- International Code
- 009
- US Codes
- 021; 023; 026; 036; 038
- First use of NOVARTIS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
- First use of NOVARTIS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 041
- US Codes
- 100; 101; 107
- First use of NOVARTIS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
- First use of NOVARTIS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
- First use of NOVARTIS anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- G
- International Code
- 045
- US Codes
- 100; 101
Who owns NOVARTIS?
Correspondent
- Maury M. Tepper, III Tepper & Eyster, PLLC
- 3724 BENSON DR
- RALEIGH, NC 27609
- United States
Recent News about NOVARTIS
Novartis Asks SCOTUS to Rein in CAFC and Ninth Circuit Approach to Panel Rehearing Decisions Tweet this
Novartis to Appeal CAFC’s ‘Unprecedented’ U-Turn in Ruling on Multiple Sclerosis Drug Claims to SCOTUS Tweet this
In Dissent to CAFC Ruling for Novartis on Written Description, Chief Judge Argues ‘Silence is not Disclosure’ Tweet this
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io